Click CAR-T cell engineering for robustly boosting cell immunotherapy in blood and subcutaneous xenograft tumor.
Bioact Mater
; 6(4): 951-962, 2021 Apr.
Article
in En
| MEDLINE
| ID: mdl-33102938
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Bioact Mater
Year:
2021
Document type:
Article
Country of publication:
China